Kintor PharmaceuticalKNTPF 24 Days Inventory is 74.30 as of Dec. 2025, which is 30% below its 10-year median of 105.40. GuruFocus rates KNTPF with a GF Score™ of 24/100. The stock has 3 warning signs investors should review. Among 638 Biotechnology companies, Kintor Pharmaceutical ranks better than 76.02% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Kintor Pharmaceutical's Inventory Turnover for the
six
months ended in Dec. 2025 was 2.46.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Kintor Pharmaceutical's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.28.
Kintor Pharmaceutical (OTCPK:KNTPF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Kintor Pharmaceutical's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Kintor Pharmaceutical's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Kintor Pharmaceutical Days Inventory Related Terms
Kintor Pharmaceutical Days Inventory Historical Data
* Premium members only.
The historical data trend for Kintor Pharmaceutical's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KNTPF vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Kintor Pharmaceutical's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kintor Pharmaceutical Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kintor Pharmaceutical's Days Inventory distribution charts can be found below:
* The bar in red indicates where Kintor Pharmaceutical's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kintor Pharmaceutical (KNTPF) has a Days Inventory of 74.30 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Kintor Pharmaceutical and its competitors. This is 30% below median its historical median of 105.40. Over the past decade, Kintor Pharmaceutical's Days Inventory has ranged from 83.10 to 5,325.69. According to the industry distribution chart, Kintor Pharmaceutical ranks #153 out of 638 companies in the Biotechnology industry, placing it in the top 24%.
Is Kintor Pharmaceutical's Days Inventory too high?
Kintor Pharmaceutical's current Days Inventory of 74.30 is 30% below median its 10-year median of 105.40. Over the past 10 years, this metric has ranged from a low of 83.10 to a high of 5,325.69. The Biotechnology industry median Days Inventory is 183.88. Kintor Pharmaceutical's value of 74.30 is 59.6% below this industry median. Based on the distribution chart, Kintor Pharmaceutical ranks #153 out of 638 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Kintor Pharmaceutical has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Kintor Pharmaceutical's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kintor Pharmaceutical ranks #153 out of 638 companies for Days Inventory. This places Kintor Pharmaceutical in the top 24% of its industry — outperforming the majority of peers. The industry median Days Inventory is 183.88. Kintor Pharmaceutical's value of 74.30 is 59.6% below this benchmark. Historically, Kintor Pharmaceutical's own Days Inventory has ranged from 83.10 to 5,325.69 over the past decade. While the company's 10-year median is 105.40 vs. the industry median of 183.88, Kintor Pharmaceutical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kintor Pharmaceutical's current Days Inventory of 74.30 is 59.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Kintor Pharmaceutical and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kintor Pharmaceutical's current Days Inventory is 74.30, which is 30% below median its own 10-year median of 105.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kintor Pharmaceutical stock overvalued right now?
Kintor Pharmaceutical (KNTPF) has a current Days Inventory of 74.30. The current Days Inventory is 74.30, which is 30% below median its 10-year median of 105.40 and 59.6% below the Biotechnology industry median of 183.88. Kintor Pharmaceutical's overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Kintor Pharmaceutical (KNTPF), the current Days Inventory is 74.30 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kintor Pharmaceutical Ltd is a clinical-stage novel drug developer in China, focusing on developing therapeutic drugs for unmet medical needs. Its pipelines cover indications of dermatology, such as AGA and acne vulgaris, and indications of tumors, catering to the unmet medical needs of patients and cosmetics consumers globally. The Group's cosmetic product types include anti-hair loss, acne treatment, and skin whitening products. Kintor's pipeline consists of various drug candidates such as KX-826, AR-PROTAC Compound (GT20029), GT1708F (Hedgehog/SMO Inhibitor), GT0486, and ALK-1 Antibody (GT90001). It has only one reportable operating segment, which is engaged in the research and development of medicine products and extends to functional cosmetics and raw materials.
24GF Score
Get the complete analysis for KNTPF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KNTPF has been successfully added to your 
